Bristol Myers Squibb Director of Business Development Salary
The average Bristol Myers Squibb Director of Business Development earns an estimated $198,016 annually, which includes an estimated base salary of $151,778 with a $46,238 bonus. Bristol Myers Squibb's Director of Business Development compensation is $31,750 more than the US average for a Director of Business Development. Director of Business Development salaries at Bristol Myers Squibb can range from $120,000 - $290,000.
The Business Development Department at Bristol Myers Squibb earns $531 more on average than the Engineering Department.
Last updated 3 months ago.
- $151,778
- avg. base
- $46,238
- avg. bonus
Director of Business Development Salaries at Bristol Myers Squibb
Directors of Business Development earn $5,331 more than Directors of Business Development.
Compensation at Bristol Myers Squibb by Department
The Business Development Department averages $531 more than the Engineering Department, and $37,234 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Bristol Myers Squibb reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Bristol Myers Squibb reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Bristol Myers Squibb Rate Their Compensation
The majority of Directors of Business Development at Bristol Myers Squibb believe they're compensated fairly. 100% of Directors of Business Development at Bristol Myers Squibb say they receive annual bonuses, and the vast majority (82%) are satisfied with their benefits. See more compensation ratings at Bristol Myers Squibb
